Refrances
1. Goodgame RW, Genta RM, White AC, Chappell CL. Intensity of infection
in AIDS-associated cryptosporidiosis. The Journal of infectious
diseases. 1993;167(3):704-9.
2. Kotler DP. Gastrointestinal manifestations of human immunodeficiency
virus infection. Advances in internal medicine. 1995;40:197-242.
3. Xiao L. Molecular epidemiology of cryptosporidiosis: an update.
Experimental parasitology. 2010;124(1):80-9.
4. Goodgame RW, Genta RM, White AC, Chappell CL. Intensity of Infection
in AIDS-Associated Cryptosporidiosis. The Journal of Infectious
Diseases. 1993;167(3):704-9.
5. Tzipori S, Ward H. Cryptosporidiosis: biology, pathogenesis and
disease. Microbes and infection. 2002;4(10):1047-58.
6. Chen XM, Keithly JS, Paya CV, LaRusso NF. Cryptosporidiosis. The New
England journal of medicine. 2002;346(22):1723-31.
7. Kotler DP. Gastrointestinal manifestations of human immunodeficiency
virus infections. Adv Int Med. 1995;40:197-242.
8. Miao YM, Awad-El-Kariem FM, Franzen C, Ellis DS, Müller A, Counihan
HM, et al. Eradication of cryptosporidia and microsporidia following
successful antiretroviral therapy. Journal of acquired immune deficiency
syndromes (1999). 2000;25(2):124-9.
9. Maggi P, Larocca AM, Quarto M, Serio G, Brandonisio O, Angarano G, et
al. Effect of antiretroviral therapy on cryptosporidiosis and
microsporidiosis in patients infected with human immunodeficiency virus
type 1. European journal of clinical microbiology & infectious diseases
: official publication of the European Society of Clinical Microbiology.
2000;19(3):213-7.
10. Manabe YC, Clark DP, Moore RD, Lumadue JA, Dahlman HR, Belitsos PC,
et al. Cryptosporidiosis in patients with AIDS: correlates of disease
and survival. Clinical infectious diseases : an official publication of
the Infectious Diseases Society of America. 1998;27(3):536-42.